• Publications
  • Influence
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
This part of the EFISG guidelines focuses on non-neutropenic adult patients. Only a few of the numerous recommendations can be summarized in the abstract. Prophylactic usage of fluconazole isExpand
  • 790
  • 54
  • PDF
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.
The burden of human disease related to medically important fungal pathogens is substantial. An improved understanding of antifungal pharmacology and antifungal pharmacokinetics-pharmacodynamics hasExpand
  • 335
  • 26
  • PDF
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus onExpand
  • 362
  • 20
  • PDF
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and toExpand
  • 299
  • 14
  • PDF
Changing patterns and trends in systemic fungal infections.
  • M. Richardson
  • Medicine
  • The Journal of antimicrobial chemotherapy
  • 1 September 2005
Invasive mycoses are a significant and growing public health problem. Although bloodstream infections with Candida albicans may be decreasing in frequency, the number of persons at risk for themExpand
  • 475
  • 13
  • PDF
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Invasive candidiasis (IC) is a relatively common syndrome in neonates and children and is associated with significant morbidity and mortality. These guidelines provide recommendations for theExpand
  • 198
  • 13
  • PDF
Changing epidemiology of systemic fungal infections.
Species of Candida and Aspergillus remain the most common causes of invasive fungal infections, but other yeasts and filamentous fungi are emerging as significant pathogens. Opportunistic yeast-likeExpand
  • 415
  • 11
  • PDF
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.
The aetiological agents of many invasive fungal infections are saprobes and opportunistic pathogens. Some of these fungi are darkly pigmented due to melanin production and traditionally have beenExpand
  • 182
  • 10
  • PDF
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has theExpand
  • 146
  • 10
  • PDF
Novel immunologic classification of aspergillosis in adult cystic fibrosis.
BACKGROUND Patients with cystic fibrosis (CF) demonstrate a wide range of hypersensitivity responses to Aspergillus, beyond allergic bronchopulmonary aspergillosis, which require classification. Expand
  • 147
  • 9